Patents by Inventor Patrice LARGER

Patrice LARGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage principle for drugs useful for treating neoplastic diseases
    Patent number: 11633383
    Abstract: The present invention provides a novel dosage principle for compounds of formula I and pharmaceutically acceptable derivatives thereof as defined in the claims, wherein said compound or pharmaceutically acceptable derivative thereof is intravenously administered to said patient over a period of at least about 8 hours, wherein the dose of the compound of formula I or pharmaceutically acceptable derivative thereof is at least the molar equivalent of about 45 mg/m2 of the dihydrochloride salt of the compound of formula I-B as defined in the claims.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: April 25, 2023
    Assignee: Basilea Pharmaceutica International AG
    Inventors: Marc Engelhardt, Anne Schmitt-Hoffmann, Patrice Larger
  • NOVEL DOSAGE PRINCIPLE FOR DRUGS USEFUL FOR TREATING NEOPLASTIC DISEASES
    Publication number: 20200237730
    Abstract: The present invention provides a novel dosage principle for compounds of formula I and pharmaceutically acceptable derivatives thereof as defined in the claims, wherein said compound or pharmaceutically acceptable derivative thereof is intravenously administered to said patient over a period of at least about 8 hours, wherein the dose of the compound of formula I or pharmaceutically acceptable derivative thereof is at least the molar equivalent of about 45 mg/m2 of the dihydrochloride salt of the compound of formula I-B as defined in the claims.
    Type: Application
    Filed: May 15, 2018
    Publication date: July 30, 2020
    Inventors: Marc ENGELHARDT, Anne SCHMITT-HOFFMANN, Patrice LARGER